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INTRODUCTION
Bilateral orchiectomy is a major therapeutic option
in the management of patients with advanced
carcinoma of the prostate and in our environment
and centres, it is the main modality available . The
current therapeutic strategy of newly diagnosed
prostate cancer is however dependent on the stage of
the disease. While most organ-confined diseases are
subjected to radical prostatectomy or brachytherapy,
the choice for advanced carcinoma of the prostate is
based on androgen manipulation .
The effects of androgen on haematopoiesis have
been studied extensively, and normocytic,
normochromic anaemia has been found to be
associated with androgen deprivation . Various
studies have also shown that haemoglobin levels
declined in parallel with serum testosterone from
normal levels, rising again on return of the serum
testosterone to normal values. No associated
changes were found in the levels of serum
erythropoeitin . In our practice, we observed that





E-MAIL: jayceeorakwe @ yahoo.com
anaemia developed in our patients after bilateral
orchiectomy for advanced carcinoma of the prostate,
such anaemia sometimes being of sufficient severity
to warrant blood transfusions. We also noted from the
available literature that studies have been done on the
anaemia associated with bilateral orchiectomy .
These studies were done on Caucasians and non-
black races. Based on these earlier observations in
other environments, clinical settings and racial
groups, we decided to study systematically our
patients with carcinoma of the prostate who were
treated with bilateral orchiectomy. This is a report of
the observations made on the anaemia associated
with bilateral orchiectomy for advanced carcinoma of
the prostate in tropical sub-SaharanAfrica.
All patients who presented to the authors with
advanced carcinoma of the prostate and were treated
with bilateral orchiectomy were studied. The patients
presented between July 1, 2000 and June 30, 2004 at
the Nnamdi Azikiwe University Teaching Hospital,
Nnewi, Nigeria, and the Macbenson Hospital,
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To study postorchiectomy anaemia in black Nigerian patients who had bilateral orchiectomy for
advanced carcinoma of the prostate. Anaemia has been observed in similar studies done on Caucasians and
non-black patients in non-tropical environments
: Consecutive patients with advanced carcinoma of the prostate who were managed
by the authors over a four-year period, and who were treated with bilateral orchiectomy were prospectively
studied. They also satisfied the set criteria for inclusion in the study.
: Thirty-six patients were studied. The mean age was 71 years (SD=7.6). Preoperative white blood cell
count with blood film examination, and serum urea and creatinine were within normal limits and remained so
for the duration of the study. The mean value of the haemoglobin concentration dropped significantly from
11.9g/dl to 10.1g/dl at six months (p<0.005). The prostate specific antigen decreased from a mean preoperative
value of 62.2ng/ml (SD=58.6) to a mean postoperative nadir of 2.9ng/ml (SD=1.3) after three months.
: In Nigerians, there is a statistically significant decrease in the heamoglobin concentration after
bilateral orchiectomy This should be closely monitored, and treated when indicated.
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Onitsha, Nigeria. They were all of the Black African
race. Criteria for inclusion in the study were as
follows: -
1. Histologically proven carcinoma of the
prostate
2. Normal pre-operative (baseline) haemoglobin
concentration and white blood cell count
including blood film.
3. Normal pre-operative renal function that also
remained normal for the duration of the study.
4. Adequate post-operative follow up period of at
least six months
5. Evidence of complete response to orchiectomy
with no evidence of disease progression during
the period of study
6. Absence of radiological evidence of skeletal
metastasis
7. Absence of any other explanation for the
anaemia e.g haematological disorders.
Thus, the baseline evaluation included a full blood
count with a blood film examination, serum urea and
creatinine, serum prostate specific antigen, chest x
-ray, and x-ray of the lumbo-sacral spine and pelvis.
For the purpose of this study, the evaluation of the
full blood count was repeated postoperatively every
month for three months, and then at six months.
Serum urea and creatinine and serum PSA were
repeated at least once within the duration of the
study, usually between the third and the sixth month.
Haemoglobin concentrations were estimated
monthly within the preceding 3-6 months before
operation. If it was found that the haemoglobin
concentration had decreased through one or two
succeeding assessments during the period, the
patient was excluded from further evaluation for the
purpose of this study.Haemoglobin concentration
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value below which anaemia is suggested for the
ordinary Nigerians is 11gm/dl and this value was
applied in this study. Statistical analysis was done
using simple descriptive statistics and the unpaired
students 't'-test. Fisher's F-test of differences of
variance was always applied before the use of the t-
test, and the z-test used if it was significant. Accepted
level of significance was p<0.05.
Forty-four patients presented during the period, 34 of
them at the Nnamdi Azikiwe University Teaching
Hospital, and 10 at MacBenson Hospital. Of these
only 36 patients satisfied the set criteria and were
studied. The mean age of the patients studied was
71.1 (SD=7.6) years, with a median of 71years, and a
range of 56-83 years.The clinical stage of the prostate
c a n c e r i n c l u d e d 2 0 p a t i e n t s w i t h T 3
(Stage C) and 16 patients with T4 (Stage D). There
was no evidence of disease progression during the
period of study.
Pre-operative values of the white blood cell count,
serum urea and creatinine (Table I) were within the
normal limits of 4 11000/mm , 2-6mmol/litre, and
60-120umol/litre respectively, and they remained
within these normal limits for the duration of the
study. Blood film studies were normal. The mean
prostate specific antigen value decreased from 62.2
(SD=58.6) ng/ml preoperatively to a mean nadir of
2.9(SD=1.3) ng/ml after 3 months. The preoperative
range of values was 10.2-226ng/ml with a median of
50ng/ml, and the postoperative range was 1.4-
6.7ng/ml with a median of 2.7ng/ml.
Table II shows the postorchiectomy haemoglobin
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3mt Prp >3mt Prp >3mt Prp >3mt
MEAN VALUE 62.18 2.93 6410 6320 4.81 4.60 102.33 98.4
STANDARD DEVIATION 54.58 1.26 2190 1820 0.92 0.83 13.51 9.8
MEDIAN 50.00 2.70 5800 6100 4.95 4.72 107 103.2
RANGE 10.20 1.40 4100- 4200 3.3 2.6 55 7 3
-226 -6.70 10800 -10600 - 6.2 -5.3 118 -110
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However, in 21(58.3%) patients, the haemoglobin
concentration fell below 11.0gm/dl at some point
during the postorchiectomy period. In 4 patients,
either because of the severity of the anaemia alone
(<7g/dl) or because of the development of anaemic
symptoms (fatigue, dyspnoea, dizziness, loss of
appetite inability to concentrate), blood transfusions
had to be given during the later course of the study. In
all our studied patients, the levels of the haemoglobin
concentrations estimated at monthly intervals
preoperatively were either stable, or were improved
under our pre-operative care.
11.9g/dl, the concentration fell to 11.3g/dl at 1
month, 10.9g/dl at 2 months, 10.6g/dl at 3 months
and 10.1g/dl at 6 months. The preoperative mean
haemoglobin concentration was compared with the
under our pre-operative care.postoperative values as
shown in Table III.
The preoperative value of the haemoglobin
concentration was statistically significantly different
from the mean values at each month of evaluation
(P<0.005). The mean drop of haemoglobin from the





: Postorchiectomy Haemoglobin Concentrations
MONTHS NO OF MEAN HB STANDARD MEDIAN RANGE
POST-OP PATIENTS (g/d1) DEVIATION
O(Pre-op) 36 11.9 1.3 11.7 11.1-14.7
1 36 11.3 1.1 11.3 9-13.7
2 36 10.9 1.2 10.9 7.6-13.7
3 34 10.6 1.1 10.7 7.9-13.2
6 32 10.1 0.9 10.6 9.2-12.6
Comparison of PreoperativeAnd Postoperative Haemoglobin Concentrations
COMPARED GROUPS MEAN DIFFERENCE “t” p value
IN HB CONC.(g/d1) (P<0.05)
Preoperative vs .1 month 0.6 2.17 <0.005st
Preoperative vs .2 month 1.0 3.32 <0.0005
Preoperative vs .3 month 1.3 4.85 <0.0005




that there was response to the orchiectomy with no
evidence of disease progression during the period of
study. In all the cases, the PSA dropped to a nadir by
three months and remained so during the period of the
study. Renal failure that could be a source of anaemia
in such urological patients was excluded in all the
patients by the estimation of the serum urea and
creatinine levels. We tried to exclude anaemia of
chronic diseases and other factors that may cause a
coincidental drop in haemoglobin concentration by
ensuring a normal preoperative haemoglobin
concentration and also proposing exclusion for
patients whose monthly preoperative haemoglobin
concentrations were observed to have had a decline
whatever the cause. However, none of our patients
was so excluded.
Our study provides no pathophysiological
explanation for the decrease in haemoglobin
DISCUSSION
This study indicates that in our environment, and
probably in the Black (Negro) race too, there is a
statistically significant decrease in haemoglobin
concentration in the patients after bilateral
orchiectomy for advanced carcinoma of the prostate.
In our centres, bilateral orchiectomy is the main
modality available for the treatment of advanced
carcinoma of the prostate.
Potential confounding factors for anaemia in
advanced carcinoma of the prostate include bone
marrow involvement and the anaemia caused by the
burden of chronic diseases. It is to limit these
confounders that the patients with evidence of
skeletal metastasis were excluded within the
facilities available to us. We also ensured that the
peripheral blood films were not suggestive of any
bone marrow depressing or replacing process, and
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concentration but we believe, as has been shown by
other studies, that it was due to the androgen
deprivation from the bilateral orchiectomy . Such
anaemia is usually normocytic and normochromic
and this was our finding in this study. Similar
normocytic and normochromic anaemia have also
been demonstrated using monotherapy with LHRH
analogues, which achieve similar mode of androgen
deprivation as bilateral orchiectomy. Anaemia has
however not been found in patients treated with
antiandrogen monotherapy, which has a different
mode of androgen deprivation .
Though we have not evaluated the treatment of such
orchiectomy-induced anaemia in our study, we
however ensured that before and during the study, all
the patients were on iron supplementation therapy.
This was to ensure adequate iron stores in the
patients, a habit we had developed earlier in our pre-
study postorchiectomy patients on observing
anaemia in them.
The anaemia observed in the patients with advanced
carcinoma of the prostate after bilateral orchiectomy
in our environment is real and similar to that
observed in other races and environments. We advise
that patients who have had bilateral orchiectomy
should be closely monitored for anaemia. Prompt
treatment should be initiated in the patients who
develop severe or symptomatic anaemia because of
the effects of anaemia on the quality of life
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